No Detail Found!

Fungal Infections in Paediatric Patients with Acute Lymphoblastic Leukaemia While on Induction Chemotherapy.

Author(s)
Asim Amjad Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Rabia Muhammad Wali Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Sadia Anjum Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Abstract
Background: Acute Lymphoblastic Leukaemia (ALL) is one of the most common haematological malignancies seen in children. Despite steadily improving long-term outcomes, infections remain a major cause of morbidity and mortality in children receiving therapy for leukaemia. The incidence and risk of invasive fungal infections (IFIs) continue to rise. In some settings, IFIs caused by moulds are more frequent than those caused by yeasts, and Aspergillus spp. is the most common pathogens. The aim of the study was to determine the frequency, type of fungal infection seen during induction chemotherapy and outcomes. Methods: This observational retrospective study was conducted in paediatric oncology department at Shaukat Khanum Cancer Hospital Lahore from January 2015 to December 2016 after taking International research board (IRB) approval. The study includes all the patients aged 1-15 who were diagnosed with acute lymphoblastic leukaemia while on induction chemotherapy. The data was retrieved of 165 patients from the hospital database after informed written consent. Results: The mean age of the patients was 4.6±2.80 with range 1-15years. Total 154 (93%) of the children were of age between 1-5 years whereas only 11 (6.7%) were between 5-10 years. Male sex was predominant in 117 (70.9%) and 48 (29.1%) were girls. Pre-B Acute lymphoblastic leukaemia was diagnosed in 93.3% of the patients and rest 11 (6.7%) were diagnosed with Pre-T Acute lymphoblastic leukaemia. NCI Standard risk patients were 132 (80%) and 33 (20%) were stratified as high risk. Fungal infections were documented in 18 (11%) patients out of which 7(39%) were probable infections, and only 11 (61%) were proven fungal infections. Aspergillus was the commonest organism in 5 (28%) patients. Death was observed in 21 (13%) patients and causes were sepsis due to infections in 18 (86%) out of which fungal infections were 11(61%), bacterial 4(22%), combine bacterial and fungal 3(17%). Remaining 3 (14%) patients death causes include, neutropenic colitis was observed in first patient, second patient died of infection without any identifiable focus, and third patient died due to chemotherapy related toxicity. Conclusion: Our study concludes that the fungal infection was the most common cause of mortality in induction in our patients. A prospective study in the form of clinical trial is needed to see if use of prophylactic antifungal can improve outcomes in our setting.
Publication Details
Page(s) 8-11
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 31, Issue: 1, Year: 2019

Request the full text from PASTIC

References
JainS,KapoorG, 2015.Invasive aspergillosis in children with acute leukemia at a resource-limited oncology center,J Pediatr Hematol Oncol 37 e1 -5
FadooZ,NisarI,YousufF,LakhaniLG,AshrafS,ImamU, 2015.Clinical Features and Induction Outcome of Childhood Acute Lymphoblastic Leukemia in a Lower/Middle Income Population: A Multi-Institutional Report From Pakistan,Pediatric Blood Cancer 62 1700 -8
2017.Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study,Int J Hematol 106 221 -8
1997.Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature,Haematologica 82 297 -304
Vazquez L, 2016.Antifungal prophylaxis in immune compromised patients,Mediterr J Hematol Infect Dis 8 e2016040 -
HoDY,LinM,SchaenmanJ,RossoF,LeungAN,CourtreSE, 2011.Yield of diagnostic procedures for invasive fungal infections in neutropenic febrile patients with chest computed tomography abnormalities,Mycoses 54 59 -70
BarrPM,CregerRJ,BergerNA, 2011.Pharmacology of Acute Lymphoblastic Leukemia Therapy,Adult Acute Lymphocytic Leukemia 127 -44
HouriganMJ,GoldstoneAH, 2010.,Acute Lymphoblastic Leukemia: Epidemiology. Adult Acute Lymphocytic Leukemia 77 -87
2015.Serum galactomannan index for early prediction of mortality in immune compromised children with invasive pulmonary aspergillosis,BMC Infect Dis 15 271 -
BaddleyJW,StroudTP,SalzmanD,PappasPG, 2001.Invasive mold infections in allogeneic bone marrow transplant recipients,Clin Infect Dis 32 1319 -24
FisherBT,KavcicM,LiY,SeifAE,BagatellR,HuangYS, 2014.Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia,Clin Infect Dis 58 502 -8
2015.Causative Pathogens of Febrile Neutropaenia in Children Treated for Acute Lymphoblastic Leukaemia,Ann Acad Med Singapore 44 530 -4
Sahbudak BalZ,Yilmaz KarapinarD,KaradasN,SenS,Z , Akinci,AB, 2015.Mycoses proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital,Mycoses 58 225 -32
SunY,HuangH,ChenJ,LiJ,MaJ,LiJ, 2015.Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China,Tumour Biol 36 757 -67
LundB,ÅsbergA,HeymanM,KanervaJ,Harila-SaariA,HasleH, 2011.Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia,Pediatr Blood Cancer 56 551 -9
2007.,Ann Trop Paediatr 27 141 -7
MarrKA,SeidelK,SlavinMA,BowdenRA,SchochHG,FlowersME, 2000.Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasisrelated death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial,Blood 96 2055 -61
2008.,Cancer 113 376 -82
2013.Minireview: host defence in invasive aspergillosis,Mycoses 56 403 -13
2012.Invasive aspergillosis in the intensive care unit,Ann N Y Acad Sci 1272 31 -9
PaganoL,GirmeniaC,MeleL,RicciP,TostiME,NosariA, 2001.Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program,GIMEMA Infection Program. Haematologica 86 862 -70
MuhlemannK,WengerC,ZenhausernR,TauberMG, 2005.Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies,Leukemia 19 545 -50
KurosawaM,YonezumiM,HashinoS,TanakaJ,NishioM,KanedaM, 2012.Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies,Int J Hematol 96 748 -57
NucciM,SpectorN,BuenoAP,SolzaC,PerecmanisT,BachaPC, 1997.Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer,Clin Infect Dis 24 575 -9
MarrKA,SeidelK,WhiteTC,BowdenRA, 2000.Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole,J Infect Dis 181 309 -16
MarrKA,CarterRA,CrippaF,WaldA,CoreyL, 2002.Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients,Clin Infect Dis 34 909 -17
0

Citations

0

Downloads

60

Views